BioPharmX Corporation (NYSE:BPMX) recorded a trading volume of 2.7 million shares, above its 90-day volume average of 2.08 million shares. The stock kicked off the session at $0.12 and later approached $0.11 with a change of -4.88%.BioPharmX Corporation (BPMX) Analyst Opinion
BioPharmX Corporation has a consensus outperform rating from 2 Wall Street analysts, and the number of shares currently sold short amount to at least 7.11% of shares outstanding. The stock sank -43.75% last month and is down -70.27 this year. Wall Street is only getting more bullish on the stock, with 2 of analysts who cover BPMX having a buy-equivalent rating. Analysts have placed a $1.8 price target on BioPharmX Corporation, suggesting a 1536.36% gain from recent close. It’s currently trading about -87.6% below its 52-week high.
BioPharmX Corporation (BPMX) surprised the stock market in its last reported earnings when it earned -$0.04 a piece versus the consensus-estimated -$0.05. Its revenue totaled $20000 down 0% from the previous quarter.BioPharmX Corporation (NYSE:BPMX) Intraday View
This stock (BPMX) is ahead of its 52-week low with 5.1%. Its last month’s stock price volatility remained 9.53% which for the week stands at 9.76%. The share price has moved backward from its 20 days moving average, trading at a distance of -22.39% and stays -45.37% away from its 50 days moving average. Over the last five days, shares have faced -7.26% losses and now is down -72.32% since hitting its 200-day moving average of $0.3243. BioPharmX Corporation (BPMX) has made its way to a 12-month decline of -70.74%.
Turning to IMAX Corporation (NYSE:IMAX), its shares were trading at $24.9 a gain of $1.15, on the trading floor. The stock, after opening at $23.7, touched a high of $25 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2. IMAX Corporation has 2 buy ratings, 2 holds and 0 sells even after the stock tumbled -28.03% from its high of $34.60 to a $1.62 billion market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2.15 to 2.15 during a month. Analysts set a 12-month price target of $30.08 a share. The target implies a 20.8% spike from where the shares are currently trading. Also, the current price highlights a discount of 40.56% to analysts’ high consensus price target.IMAX Corporation (NYSE:IMAX) Intraday Trading
The counter witnessed a trading volume of 0.76 million shares versus an average volume of 1 million shares during last trading session. Its last month’s stock price volatility remained 3.45% which for the week approaches 3.48%. The lowest price the stock reached in the last trading day was $23.6995 and compares with the $17.58 52-week low. The stock recovered 41.68% since its low point and has performed -20.7% year-to-date.